As 2026 begins, the pharmaceutical industry is undergoing a radical decentralization, moving away from a reliance on a few large academic centers toward a "site-less" model. This shift, accelerated by the global adoption of mobile health technologies, allows patients to participate in clinical trials from their own homes, regardless of their proximity to a major city. This inclusivity is not...
Italiano 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek